Lorem Springs CEO applies her institutional literacy framework to one of public health's most discussed systems, the FDA drug approval process, positioning health literacy as a core leadership skill in her 10th Xraised podcast episode.
-- Shannon Kacherovich, Founder and CEO of Lorem Springs, has shared her institutional literacy expertise in her tenth Xraised podcast episode, applying her framework for making complex systems legible to the people they govern to the FDA drug approval process.
Lorem Springs delivers leadership communication consultancy and institutional literacy frameworks for organisations navigating complex, high-stakes environments. Kacherovich's work positions evidence literacy, transparent communication, and systemic accountability as core leadership competencies and the foundation of genuine public trust.
FDA Drug Approval Process: A Framework for Public Understanding
Kacherovich walks us through the FDA's approval pathway, explaining how its sequential structure is built on evidence-based decision making. Pre-clinical animal trials establish a basic safety profile.
Three clinical phases follow, each contingent on clearing the previous.
Phase 1 tests on healthy participants to confirm human tolerability.
Phase 2 introduces patients with the relevant condition, half receiving the drug, half a placebo, to establish effectiveness.
Phase 3 broadens the sample across age, gender, nationality, and racial background, establishing correct dosage and examining drug interactions with other medications.
Each attempt is anonymised through a unique identifier, preventing any stage from being influenced by prior outcomes. Trials can be halted mid-process if safety concerns emerge. The system is designed to reward rigour over speed.
Emergency Authorisation: Addressing Common Misconceptions
Kacherovich addresses public misconceptions around emergency FDA authorisation, which came under significant scrutiny during the COVID-19 pandemic. She clarifies that emergency authorisation does not bypass clinical trials or lower evidentiary standards. Every drug moving through it undergoes identical trial phases to those in the traditional pathway. What changes is logistics; manufacturing begins in parallel so that distribution can follow approval immediately - with the evidentiary framework and standards remaining fully intact.
Kacherovich highlights the regulatory distinction between FDA-approved pharmaceutical products and dietary supplements or wellness products, which operate under a different framework. The actuary founder outlines how these categories differ in their approval requirements, noting that consumer health literacy tools can support more informed decision-making when navigating these distinctions.
Institutional Literacy as a Leadership Imperative
Kacherovich's core argument throughout the episode is that understanding the systems governing public health is a leadership issue. Through Lorem Springs, she works with organisations to build the institutional literacy, communication transparency, and evidence-based frameworks that enable leaders and their teams to navigate complex environments with clarity and confidence.
Her tenth Xraised episode is available to watch here, covering her broader perspective on building human-centred organisations in a fast-changing and increasingly complex business environment.
About Lorem Springs
Lorem Springs is a Boston-based leadership communication consultancy founded by Shannon Kacherovich, Actuary and CEO. The firm delivers institutional literacy frameworks, leadership communication consultancy, and evidence-based systems for organisations operating in complex, high-stakes environments.
Connect with Actuary Founder and CEO, Shannon Kacherovich on LinkedIn and learn more about Lorem Springs here.
Sources: fda.gov
Contact Info:
Name: Gianmarco
Email: Send Email
Organization: Xraised
Website: http://www.xraised.com
Release ID: 89189582
If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.
